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Abstract
Background: Hashimoto Thyroiditis (H.T.) is a destructive autoimmune thyroid condition whose
precise molecular pathogenesis remains unclear. ret/PTC-1 is a chimeric transcript which has been
described in autoimmune thyroid disease (AITD) and thyroid neoplasia. The purpose of this study
was to observe the immunogenic effect exposure to H.T. and control lymphocyte supernatant
would have on normal (Nthy-ori) and ret/PTC-1 (TPC-1) expressing thyroid cell line models.
Results: A 2 × 2 matrix comprising Nthy-ori and TPC-1 cell lines and H.T. and control lymphocyte
supernatant was designed and utilised as follows; activated lymphocytic supernatant from a H.T.
and normal control were co-cultured with a cell line derived from normal thyroid (Nthy-ori) and
also a cell line derived from a papillary thyroid carcinoma that endogenously expresses ret/PTC-1
(TPC-1). The co-cultures were harvested at 0, 6 and 18 hour time points. Gene expression analysis
was performed on RNA extracted from thyrocytes using TaqMan® Immune profiling Low-Density
Arrays (Applied Biosystems, CA, USA) comprising gene expression markers for 93 immune related
targets plus 3 endogenous controls.
Stimulation of the normal thyroid cell line model with activated T cell supernatant from the H.T.
donor yielded global up-regulation of immune targets when compared with control supernatant
stimulation. In particular, a cohort of targets (granzyme B, CD3, CD25, CD152, CD45) associated
with cytotoxic cell death; T cell receptor (TCR) and T cell signaling were up-regulated in the
normal cell line model. When the ret/PTC-1 expressing thyroid cell line was co-cultured with H.T.
lymphocyte supernatant, in comparison to control supernatant stimulation, down-regulation of the
same subset of immune targets was seen.
Conclusion: Co-culturing H.T. lymphocyte supernatant with a normal thyroid cell line model
leads to over-expression of a subset of targets which could contribute to the pathogenesis of H.T.
via cytotoxic cell death and TCR signalling. Stimulation of the ret/PTC-1 positive cell line with the
same stimulus led to a down-regulated shift in the gene expression pattern of the cohort of immune
targets. We hypothesize that ret/PTC-1 activation may dampen immunogenic responses in the
thyroid, which could possibly facilitate papillary thyroid carcinoma development.
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Background
Lymphocytic infiltration is a feature of many thyroid dis-
eases, both benign and malignant. Hashimoto Thyroiditis
(H.T.), an autoimmune thyroid disease, is characterised
morphologically by inflammatory infiltrate and diffuse
fibrosis which typically leads to progressive thyrocyte
depletion. This loss of thyrocyte capacity results in
impaired thyroid hormone production and clinical
hypothyroidism. However the exact molecular mecha-
nisms by which thyrocyte destruction occurs remains to
be seen.
The  ret/PTC oncogenes represent activated, rearranged
forms of the RET  proto-oncogene. They were initially
thought to be specific for papillary thyroid carcinoma
(PTC), but have subsequently been found in benign thy-
roid conditions such as Hashimoto Thyroiditis [1-3]. The
ret/PTC oncogenes are formed as a result of chromosomal
inversions within chromosome 10 resulting in the fusion
of the tyrosine kinase domain of RET to another donor
gene. The most commonly detected rearrangement is ret/
PTC-1 (~70%), in which the tyrosine kinase moiety of c-
ret is fused to the 5' end of the H4 gene [4].
The observation that ret/PTC-1 was not restricted to PTC
raised the possibility that a) H.T. might represent an early
malignant state to which some patients are able to mount
an immune response, or b) that ret/PTC-1 occurs in the
absence of malignancy and is not specific for PTC.
In either event ret/PTC-1 activation is associated with
florid lymphocytic infiltration. The objective of this study
was to investigate the immune response elicited by a nor-
mal and endogenously expressing ret/PTC-1 thyroid cell
line after co-culture with autoimmune H.T. and normal
lymphocytic supernatant using functional genomics.
Immunoprofiling TaqMan® low density arrays were used
to evaluate the expression profiles of ret/PTC-1 positive
and negative thyrocytes over a time course of co-culture
with activated T cell supernatant.
Results
TaqMan® low density array immunoprofiling data was
analyzed using SDS 2.1 software (Applied Biosystems, CA,
USA). Independent RQ studies were carried out for each
cell line. In both cell lines (Nthy-ori and TPC-1), the 6
hour time point displayed peak expression differentials
compared with T0 and between different stimuli (Normal
and H.T.).
Nthy-ori co-culture gene expression patterns
In the normal thyroid cell line model (Nthy-ori), expo-
sure to H.T. lymphocyte supernatant led to global up-reg-
ulation of 92 inflammation targets (with the exception of
one, Heme oxygenase-1 where expression between each
cohort was equivocal) in comparison to stimulation with
normal control lymphocytes. The Nthy-ori co-culture heat
map (figure 1) illustrates expression of the 93 immune
related targets assayed plus endogenous control at each
co-culture combination and time point analyzed. The
heat map demonstrates increased expression levels of tar-
gets exposed to H.T. lymphocyte supernatant compared to
control at the 6 hour time point. It also demonstrates a
reduced level of gene expression in Nthy-ori cells that
were not exposed to stimulus at the 18 and 6 hour time
points.
Figure 2 displays a subset of targets which were over-
expressed in the normal thyroid cell line model (Nthy-
ori) when exposed to H.T. lymphocytic supernatant com-
pared to control at the 6 hour time point. They included
granzyme B (GZMB), a known effector in cytotoxic cell
death, CD3, CD25, CD152 and CD45 all of which are
involved with the T cell receptor (TCR) or signaling in the
T cell.
Figure 3a–c displays the gene expression level of Fas lig-
and (FasL), CD28 and granulocyte colony stimulating fac-
tor (G-CSF) in the Nthy-ori co-culture. These targets also
displayed increased expression levels in the normal thy-
roid cell line model which was exposed to H.T. lym-
phocyte supernatant when compared to exposure to
control supernatant.
TPC-1 co-culture gene expression patterns
In the ret/PTC-1 harboring cell line, approximately 40%
of targets (with a relative quantification (RQ) value >100)
were down-regulated when stimulated with H.T. lym-
phocyte supernatant in comparison to exposure with con-
trol supernatant. The TPC-1 co-culture heat map (figure 4)
illustrates the reduction in gene expression at the TPC-1
18 and 6 hour time points where there is no exposure to
supernatant.
Figure 5 represents the gene expression pattern for
granzyme B, CD3, CD25, CD152 and CD45 in the ret/
PTC-1 positive cell line (TPC-1). As previously stated, fig-
ure 2 demonstrates the over-expression of these targets in
the normal thyroid cell line model when exposed to H.T.
lymphocyte supernatant in comparison to stimulation
with control supernatant. However figure 5 illustrates that
when a ret/PTC-1 positive thyroid cell line model is co-
cultured with H.T. supernatant; in comparison to co-cul-
ture with control supernatant, this group of targets are
under-expressed. This illustrates an important gene
expression pattern, one that demonstrates a shift in
expression of the cohort of targets when ret/PTC-1 activa-
tion is introduced.Molecular Cancer 2008, 7:44 http://www.molecular-cancer.com/content/7/1/44
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Heat map of Nthy-ori co-culture Figure 1
Heat map of Nthy-ori co-culture. This heat map represents all 93 immune targets assayed (plus endogenous control) at each 
time point/co-culture combination that RNA was extracted at. Relative quantification (RQ) values for each target were used to 
create the heat map. Red denotes genes with relative increased expression while green denotes genes with relative decreased 
expression.Molecular Cancer 2008, 7:44 http://www.molecular-cancer.com/content/7/1/44
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It is noteworthy that, in figures 2 and 5, the cell line mod-
els that were not exposed to stimulus i.e. Nthy-ori at 6 h
and TPC-1 at 6 h did not show any level of gene expres-
sion for the targets displayed. Relative quantification
(RQ) values representing all co-culture combinations/
time points for each assay have been normalized to a
house keeping gene (Glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH)) and then normalized to a calibrator
sample (un-stimulated N-thy-ori or TPC-1 at 0 hours)
according to the 2-ΔΔCt comparative threshold cycle (Ct)
method [5]. From this we can interpret that the gene
expression patterns detected are a result of stimulation
with H.T. or control lymphocytic supernatant and also the
presence or absence of the ret/PTC-1 oncogene.
Discussion
Although the pathogenic mechanisms determining thyro-
cyte destruction in Hashimoto Thyroiditis have been
extensively investigated, it is still unclear exactly how this
destructive process occurs.
Among oncogenes studied in the setting of thyroid neo-
plasia, activated c-ret -and ret/PTC-1 in particular has been
found to associate with papillary thyroid carcinoma
(PTC) and Hashimoto Thyroiditis (H.T.). Its presence has
also been noted in lesions which have an affiliated inflam-
matory infiltrate. However, despite extensive studies into
the prevalence and sequelae of the presence of activated
ret/PTC-1 it remains unclear if ret/PTC-1 activation
orchestrates, maintains or modulates the inflammatory
response so often observed as a feature of ret/PTC-1 posi-
tive lesions.
The aim of this project was to observe the immune
response elicited by a normal thyroid cell line model
upon exposure to lymphocytic supernatant derived from
a H.T. and normal donor at varying time points. To fur-
ther evaluate the role of the ret/PTC-1 oncogene in a sim-
ilar setting, we also observed the immune response
elicited by an endogenously expressing ret/PTC-1 thyroid
cell line stimulated with H.T. and normal lymphocyte
supernatant. We chose to use an endogenously expressing
ret/PTC-1 cell line rather than transfecting the normal cell
line with ret as we felt that in the setting of this experi-
ment, it was more biologically plausible to compare a nor-
mal thyroid cell line with a thyroid cancer cell line which
natively expresses the oncogene. We decided to utilise
supernatant from activated T-lymphocytes in each group
to stimulate the cell line models to ensure assessment of
gene expression accurately reflected the repertoire of the
epithelial cells alone.
Nthy-ori gene expression pattern
When thyroid cells from the Nthy-ori cell line model were
exposed to Hashimoto Thyroiditis (H.T.) lymphocyte
supernatant, a universal up-regulation of all immune tar-
Nthy-ori 6 hour co-culture Figure 2
Nthy-ori 6 hour co-culture. Figure 2 displays targets that were up-regulated in ret/PTC-1 negative thyrocytes when co-cultured 
with Hashimoto Thyroiditis lymphocyte supernatant in comparison to exposure to control lymphocytic supernatant after a 6 
hour interval.Molecular Cancer 2008, 7:44 http://www.molecular-cancer.com/content/7/1/44
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gets was observed when compared to exposure to control
lymphocyte supernatant (with the exception of Heme
oxygenase-1 where expression between each cohort was
equivocal) (figure 1).
However, within the global increased expression on stim-
ulation by H.T. supernatant, some clusters of genes
appeared to be particularly interesting. They included sub-
sets of targets which may contribute to the pathogenesis of
H.T. via cell mediated cytotoxic cell death and TCR signal-
ling.
Thyrocyte specific CD8 cytotoxic T cell responses are a piv-
otal factor in the tissue specific destruction that is seen in
H.T. Cell mediated cytoxicity is initiated through two dif-
ferent mechanisms 1) effector cell expression of death lig-
ands presented to target cells and 2) effector cell release of
exocytic granules containing perforin and granzyme B [6].
Over expression of both Fas ligand (FasL) and granzyme
B, was seen when the normal thyroid cell line model was
stimulated with H.T. lymphocyte supernatant compared
to control supernatant.
Granzyme B is a serine protease that plays an important
role in inducing apoptotic changes in target cells during
granule exocytosis-induced cytotoxicity [7] while FasL
induces apoptosis by binding to and activating its recep-
tors, which in turn bind to adaptor molecules that activate
the caspase family.
Increased expression of these cytotoxic agents in the nor-
mal thyroid cell line model exposed to H.T. lymphocyte
supernatant suggests that these targets are specifically
involved in cytotoxic cell death in H.T. leading to apopto-
sis of thyroid follicular epithelial cells and the resultant
destruction of thyroid tissue that is indicative of H.T.
Moreover, targets involved with the T cell receptor (TCR)
and T cell signalling were also up-regulated which may be
responsible for exacerbation of the destructive process
seen in H.T. These targets included CD3, CD25, CD28,
CD152 and CD45.
T cell activation requires not only the generation of an ini-
tial signal through interaction of the antigenic peptide
with the TCR-CD3 complex but also a subsequent antigen
non-specific co-stimulatory signal, provided primarily by
the interaction of CD28 on T cells with B7 molecules [8].
CD152 is implicated in this process via competitive bind-
ing to B7. CD45 is involved in maintaining protein tyro-
sine kinases in a dephosphorylated state prior to
participation in signal transduction upon subsequent TCR
ligation [9]. It is interesting to hypothesize that these over-
expressed TCR and T cell signalling associated targets may
be involved in the disease pathogenesis seen in H.T. via
dysregulation of T cell signalling and control of T cell acti-
vation resulting in the over-activity of immune responses
typically seen in autoimmune diseases such as H.T.
Expression levels for FasL, CD28 and G-CSF Figure 3
Expression levels for FasL, CD28 and G-CSF. Figure 3a-c dis-
plays gene expression levels for FasL(3a), CD28(3b) and G-
CSF(3c) expression in the Nthy-ori 6 hour co-culture. Each 
target is over-expressed in the normal thyroid cell line when 
exposed to Hashimoto Thyroiditis lymphocyte supernatant 
in comparison to exposure to control lymphocyte superna-
tant.Molecular Cancer 2008, 7:44 http://www.molecular-cancer.com/content/7/1/44
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Heat map of TPC-1 co-culture Figure 4
Heat map of TPC-1 co-culture. This heat map represents all 93 immune targets assayed (plus endogenous control) at each time 
point/co-culture combination that RNA was extracted at. Relative quantification (RQ) values for each target were used to cre-
ate the heat map. Red denotes genes with relative increased expression while green denotes genes with relative decreased 
expression.Molecular Cancer 2008, 7:44 http://www.molecular-cancer.com/content/7/1/44
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Finally, a large fold change difference (RQ value) was
observed for granulocyte colony stimulating factor (G-
CSF) when comparing thyrocytes exposed to H.T. and
control lymphocyte supernatant in the normal cell line
model (figure 3c). G-CSF elicits an effect on the immune
system via its role in monocyte/macrophage activation,
neutrophil stimulation and regulation of inflammatory
cytokine/chemokine production. One cause of tissue
damage in the thyroid is infiltration by lymphocytes and
monocytes/macrophages. The over-expression of G-CSF
in thyrocytes exposed to H.T. lymphocyte supernatant
suggests that G-CSF may play a role in promoting the
inflammatory aggravation and subsequent tissue destruc-
tion seen in autoimmune thyroid diseases such as H.T.
TPC-1 gene expression pattern
We further wanted to evaluate the expression and role of
the ret/PTC-1 oncogene in a similar context and so we
reapplied our co-culture conditions to another thyroid
cell line expressing this oncogene (TPC-1 cell line).
As previously stated, the Nthy-ori co-culture displayed up-
regulation of a discrete subset of immune targets which
may contribute to the disease pathogenesis seen in H.T.
These targets included granzyme B, CD3, CD25, CD152
and CD45; targets which are involved in apoptosis, T cell
signalling and T cell activation. In the ret/PTC-1 cell line
model, these 5 targets showed a shift in gene expression
pattern whereby they were down-regulated in ret/PTC-1
positive thyrocytes exposed to H.T. supernatant when
compared to exposure to control supernatant. There has
been much speculation surrounding the role that ret/PTC-
1 plays in the inflammatory response in ret  positive
lesions. In this study we have seen that exposure to super-
natant derived from H.T. peripheral blood mononuclear
cells (PBMCs) results in the normal thyroid cell line
model and the ret/PTC-1 positive thyroid cell line model
producing different immunogenic patterns. Perhaps the
expression of the ret/PTC-1 oncogene in the TPC-1 cell
line acts to down-regulate apoptotic and T cell signalling
targets, resulting in this change in gene expression pattern
that we have seen. As a result of this expression pattern in
the stimulated ret/PTC-1 expressing cell line, it is interest-
ing to speculate that ret/PTC-1 activation in AITD may
dampen the immune response and facilitate tumour
growth and development.
ret/PTC has been shown to function in the MAPK
(mitogen-activated protein kinase) signalling cascade by
binding adaptor proteins such as growth receptor-bound
protein 2 (GRB2), which in turn activate RAS. RAS acti-
vates AF kinases such as BRAF and its downstream signal-
ling cascade including MEK (MAP kinase) and ERK
(extracellular signal-regulated kinases or MAPK). Acti-
vated ERK1 and ERK2 translocate to the nucleus where
they activate transcription factors such as ELK-1 and
TPC-1 6 hour co-culture Figure 5
TPC-1 6 hour co-culture. Figure 5 displays how targets that were up-regulated in ret/PTC-1 negative thyrocytes (figure 2) are 
down-regulated in ret/PTC-1 positive thyrocytes when co-cultured with Hashimoto Thyroiditis lymphocyte supernatant in 
comparison to exposure to control lymphocytic supernatant after a 6 hour interval.Molecular Cancer 2008, 7:44 http://www.molecular-cancer.com/content/7/1/44
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STAT3. Hwang and colleagues [10] have demonstrated
that ret/PTC associates with and activates STAT3, while
microarray analysis has demonstrated up-regulation of
STAT3 in ret/PTC-3 thyrocytes [11]. Furthermore STAT3
has been shown to contribute to malignancy by inactivat-
ing intrinsic and extrinsic apoptotic pathways [12]. ret/
PTC activation and the resultant STAT3 transcription fac-
tor activation via the MAPK signalling cascade may be
involved in impeding apoptosis in thyrocytes by down-
regulation of granzyme B. Although a link between STAT3
activation and dysregulation of apoptotic mechanisms via
granzyme B down-regulation cannot be proven from this
study alone it is interesting to speculate that STAT3 activa-
tion through ret/PTC MAPK signalling may contribute to
malignancy in the setting of thyroid neoplasia.
Conclusion
This study has highlighted a set of immune related gene
expression markers which were shown to be up-regulated
in a normal thyroid cell line model upon exposure to H.T
lymphocyte supernatant when compared to control.
These targets included genes which could plausibly be in
involved in exacerbating the disease pathogenesis seen in
H.T. To further ascertain the extent to which the oncogene
ret/PTC-1 is involved in immunogenic responses in AITD,
we used a ret/PTC-1 positive thyroid cell line model
employing the same co-culture methods. We found that
when this cell line was stimulated with H.T. supernatant,
a shift in the immunogenic pattern was seen, whereby the
same set of immune markers were down-regulated com-
pared to control supernatant stimulation. We hypothesise
that ret/PTC-1 expression in the TPC-1 thyroid cell line
may lead to down-regulation of these immune targets.
Consequently we can speculate that ret/PTC-1 activation
in the setting of AITD may lead to under-expression of
these immune targets, resulting in tumour growth and
development. Nonetheless, this study, utilising TaqMan®
low density immune arrays, has given us further insight
into the molecular immunogenesis of H.T. and some of




Nthy-ori 3-1 (ECACC, Wiltshire, UK) represents a normal
human thyroid follicular epithelial cell line which has
been immortalised by transfection with a plasmid encod-
ing for the SV40 large T gene.
TPC-1 is a cell line derived from a papillary thyroid carci-
noma and expresses the ret/PTC-1 oncogene.
Both cell lines were grown to confluence in a humidified
atmosphere containing 5% CO2 at 37°C in the following
plating medium: RPMI 1640 with 2 m M L-glutamine
(Invitrogen-GIBCO, MD, USA), 10% foetal calf serum
(FCS) (Invitrogen-GIBCO, MD, USA), penicillin (100 U/
ml) (Invitrogen-GIBCO, MD, USA) and streptomycin
(100 U/ml) (Invitrogen-GIBCO, MD, USA).
Lymphocyte isolation
Gene expression analysis was performed at three distinct
time points for each cell type and co-culture variable; 0
hours, 6 hours and 18 hours. For each time point 12 mls
of fresh whole blood was withdrawn from the H.T. and
control subjects (lymphocytes were obtained from the
same H.T. and control donor for all experiments) into
heparinised Vacuette® collection tubes (Greiner bio-one,
Austria). Ethics approval was obtained from the Trinity
College Faculty of Health Sciences Research Ethics Com-
mittee. Heparainised whole blood was treated with
RosetteSep® Human T cell Enrichment Cocktail (StemCell
Technologies, UK), and the manufacturers' protocol for
isolation of lymphocytes was followed. Briefly, fresh
blood was incubated with RosetteSep® cocktail (50 μl/ml
of whole blood) at room temperature for 20 minutes.
Samples were diluted with an equal volume of phosphate
buffered saline (PBS) (Sigma-aldrich, MO, USA) and 2%
FCS. Diluted samples were layered on top of density
medium (Lymphoprep™, AXIS-SHIELD, Norway). Care
was taken not to mix sample and density medium prior to
centrifugation. Gradient centrifugation was performed at
4°C for 20 minutes at 1400 rpm (Eppendorf AG, 5810R,
Germany). Enriched cells were removed from the density
medium: plasma interface and washed with PBS and 2%
FCS. T cells were pelleted, resuspended and counted using
a haemocytometer. Approximately 2 × 106 T cells were iso-
lated from 12 mls of whole blood. For each subject, a 24
well plate was plated with 1 × 106 T cells in two wells. In
one of these wells, phorbol 12-myristate 13-acetate
(PMA) (Sigma-Aldrich, MO, USA) (25 ng/ml) was added
to activate the T cells. The second untreated well served as
the control.
Co-culture
After 3 days, the activated T cells were spun down and
supernatant collected was added to wells plated with 2.5
× 105 Nthy-ori cells and 2.5 × 105 TPC-1 cells for the co-
culture procedure. Table 1 shows the time points at which
RNA was extracted from the thyrocytes and the various co-
culture combinations.
Preliminary work (data not shown) co-culturing both thy-
roid cell lines with activated lymphocytes for time inter-
vals of 6 and 18 hours resulted in strong aggregation of
thyrocytes and lymphocytes impairing isolation of pure
populations of thyrocytes for gene expression analysis.
This phenomenon was most likely due to HLA incompat-
ibility and/or contact inhibition. Hence, it was decided to
extract supernatant from activated T-cells for stimulationMolecular Cancer 2008, 7:44 http://www.molecular-cancer.com/content/7/1/44
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of thyrocytes to provide a uniform trigger across both ret/
PTC-1 + and - cell types.
RNA extraction and cDNA archiving
At 0, 6 and 18 hour time points' cells were tripsinised
(Sigma-aldrich, MO, USA) and centrifuged to remove
supernatant. RNA was extracted using RNeasy ® mini kit
(Qiagen Ltd., West Sussex, UK) according to manufac-
turer's protocol. RNA quantity was assessed using a Nano-
Drop® ND-1000 Spectrophotometer (Wilmington, USA).
The RNA was reverse transcribed to single stranded cDNA
using a High Capacity cDNA Archive Kit (Applied Biosys-
tems, CA, USA) in 100 μl reactions.
Reactions contained 10 μl of buffer (10×), 4 μl of deoxy-
nucleotide triphosphate (25×), 10 μl of random primers
(10×), 5 μl of multiscribe RT enzyme (50 U/μl), 21 μl of
nuclease-free water and 50 μl of extracted total RNA (20
ng/μl).
The reactions were incubated at 25°C for 10 minutes and
37°C for 2 hours (Perkin Elmer 9600 GeneAmp PCR sys-
tem, Applied Biosystems, CA, USA).
TaqMan® low density array (TLDA)
Gene expression analysis was performed using TaqMan®
immune-profiling/inflammation low density arrays
(TLDAs). The panel of assays included in the TLDA format
is designed to simultaneously assess gene expression pat-
terns of multiple targets in a micro-fluidic system. Each
immune profiling TLDA contains lyophilised gene expres-
sion reagents (primers and probes [FAM labeled]) in a
preconfigured 384 well format (see additional file 1 for an
illustration of the gene expression reagents that were fac-
tory loaded onto the TaqMan® TLDAs). Each of the 8 sep-
arate loading ports feeds into 48 separate wells, with 4
well replicates per assay.
One sample was analysed per card. Each loading port was
filled with a 100 μl volume containing 5 μl cDNA (20 ng/
μl), 45 μl of nuclease free water and 50 μl of TaqMan® uni-
versal PCR master mix (2×). After loading, the cards were
placed in Sorvall®/Heraeus® custom buckets (Applied Bio-
systems, CA, USA) and centrifuged in a Sorvall Legend T
EASYset centrifuge (Thermo Electron Corporation, Ger-
many) for a total of 2 consecutive 1 minute spins at 1200
rpm to ensure complete distribution of the sample from
the loading port into each well. Following centrifugation,
cards were sealed with a TLDA sealer (Applied Biosystems,
CA, USA) to prevent cross contamination. Real time RT-
PCR amplification was performed on an ABI Prism® 7900
H.T. Sequence Detection system (Applied Biosystems, CA,
USA). Thermal cycling conditions were as follows: 2 min-
utes at 50°C, 10 minutes at 94.5°C, and for 40 cycles, 30
seconds at 97°C and 1 minute at 59.7°C.
TaqMan® low density array analysis
TLDA cards were analyzed with relative quantification
(RQ) documents and RQ manager software for automated
data analysis (Applied Biosystems, CA, USA). For analysis
purposes, the Nthy-ori time points and the TPC-1 time
points were analysed as two separate RQ studies. Expres-
sion values were calculated using the comparative thresh-
old cycle (Ct) method. Briefly, this technique uses the
formula 2-ΔΔCt [5] to calculate the expression of target
genes normalised to a calibrator (un-stimulated N-thy-ori
or TPC-1 at 0 hours). Glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) was selected as the endogenous con-
trol.
The threshold cycle Ct indicates the cycle number by
which the amount of amplified target reaches a fixed
threshold. The Ct data for all inflammation target genes
and GAPDH were used to create ΔCt values [ΔCt = Ct (tar-
get gene)-Ct (GAPDH)]. ΔΔCt values were calculated by
subtracting the calibrator (Nthy-ori at 0 hrs or TPC-1 at 0
hrs) from the ΔCt value of each target. Relative quantifica-
tion (RQ) values were calculated using the equation 2-ΔΔC
t.
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